Verapamil downregulates iron uptake and upregulates divalent metal transporter 1 expression in H9C2 cardiomyocytes.

Jiang, Li-Rong; Shen, Meng-Qi; Bao, Yu-Xin; Qian, Zhong-Ming

Jiang, Li-Rong; Shen, Meng-Qi; Bao, Yu-Xin; Qian, Zhong-Ming.

Affiliation

Jiang LR; Laboratory of Neuropharmacology, Fudan University School of Pharmacy, Shanghai, China.
Shen MQ; Institute of Translational and Precision Medicine, Nantong University, Nantong, China.
Bao YX; Research Center for Medicine and Biology, Zunyi Medical University, Zunyi, China.
Qian ZM; Laboratory of Neuropharmacology, Fudan University School of Pharmacy, Shanghai, China.

Fundam Clin Pharmacol ; 36(6): 985-991, 2022 Dec.

Article de En | MEDLINE | ID: mdl-35487763

Sujet(s)
Mots clés

H9C2 cells; L-type voltage-dependent Ca2+ channel (LVDCC); divalent metal tranport 1 (DMT1); non-transferrin-bound iron (NTBI); verapamil

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vérapamil / Fer Limites: Animals Langue: En Journal: Fundam Clin Pharmacol Sujet du journal: FARMACOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google